Ventilator Settings for Bronchoscopy During Mechanical Ventilation: a Randomized Controlled Study
Launched by CENTRE HOSPITALIER ARRAS · Aug 17, 2024
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how to make a procedure called fiberoptic bronchoscopy (FOB) safer for patients who are on mechanical ventilation, which is a machine that helps people breathe when they can’t do it on their own. During FOB, the machine may have trouble delivering the right amount of air because the procedure can cause increased pressure in the lungs. The study is testing new settings on the ventilator to see if they can help reduce this pressure, making the procedure easier and safer for critically ill patients.
To participate in this study, you need to be at least 18 years old and receiving mechanical ventilation due to severe breathing problems in an intensive care unit. You would also need to be under sedation and have a medical reason for needing the bronchoscopy, such as checking the airways. The study is currently recruiting participants and aims to find a better way to support patients needing this important procedure while on a ventilator. If you or a loved one are considering joining, the study team will guide you through what to expect during the trial and ensure you understand everything involved.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥18 years;
- • Acute respiratory failure requiring invasive mechanical ventilation in the intensive care unit;
- • Indication of either a fiberoptic bronchoscopy (FOB) procedure or a percutaneous tracheostomy under FOB control;
- • Patient under sedation with Richmond Agitation and Sedation Scale(RASS) ≤-2,
- • Written informed consent obtained by the patient or the patient legal representative
- Exclusion Criteria:
- • Presence of an absolute contraindication to FOB (respiratory arrest, severe acute respiratory distress syndrome (ARDS), refractory shock, uncontrolled heart rhythm disorder);
- • Patients in respiratory distress or with severe patient-ventilator desynchronies ;
- • Patients refusing FOB;
- • Pregnancy ;
- • Moribund patients (according to American Society of Anesthesiologists (ASA) Physical status score classification, class 5: high probability of death within 24 hours) or at high risk of death during the FOB procedure;
- • Patients deprived of liberty;
- • Patients under curators or guardianship.
About Centre Hospitalier Arras
Centre Hospitalier Arras is a leading healthcare institution dedicated to advancing medical research and enhancing patient care through innovative clinical trials. With a strong commitment to ethical practices and patient safety, the hospital collaborates with multidisciplinary teams of healthcare professionals to conduct rigorous studies across various therapeutic areas. By leveraging its state-of-the-art facilities and expertise, Centre Hospitalier Arras aims to contribute valuable insights to the medical community and improve treatment outcomes for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Arras, , France
Patients applied
Trial Officials
Malcolm LEMYZE, Dr
Principal Investigator
arras hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported